FDA Inspection 1013036 — Sandoz Incorporated

Sandoz Incorporated — FEI 1717759

The FDA completed an inspection of Sandoz Incorporated on Mar 29, 2017 in East Hanover, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Mar 29, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
East Hanover, NJ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.